Trena-Med-E, Trenbolone Enanthate, 200 mg/ml, 10 ml

Trenbolone Enanthate 200 mg/ml by Bioniche Pharma is a long-acting esterified parenteral solution formulated to deliver extended anabolic support. Engineered by Bioniche Pharma to ensure steady systemic activity, this specialized formulation stimulates cellular protein metabolism, drives nitrogen retention, prevents catabolic tissue degradation, and supports muscle accretion when paired with proper nutrition.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

Bioniche Pharma Trenbolone Enanthate exerts potent anabolic and androgenic effects by binding strongly to intracellular androgen receptors. The attached enanthate ester extends the pharmacokinetic profile of Bioniche Pharma Trenbolone Enanthate, enabling a gradual active release compared to short-acting options while preserving high anabolic activity. It promotes muscle protein synthesis, enhances nitrogen conservation, and inhibits catabolic glucocorticoid action. As a non-aromatizing agent, Trenbolone Enanthate by Bioniche Pharma does not convert directly to estrogen.

INDICATIONS & CLINICAL USE

• Targeted anabolic management to improve systemic nitrogen conservation, accelerate protein synthesis, and foster tissue recovery using Bioniche Pharma Trenbolone Enanthate.
• Clinical treatment of severe muscle-wasting conditions and support for lean tissue recovery in debilitated patients under qualified medical supervision.

CONTRAINDICATIONS

• Male patients with confirmed, suspected, or previously treated prostate carcinoma or breast cancer.
• Female patients presenting with breast carcinoma accompanied by hypercalcemia.
• Pregnant or nursing women due to severe risks of fetal virilization, developmental defects, and profound endocrine toxicity. Females must strictly avoid Bioniche Pharma Trenbolone Enanthate under all circumstances.
• Patients presenting with severe cardiovascular disease, advanced hepatic impairment, or major renal dysfunction.
• Known hypersensitivity or allergic response to Trenbolone Enanthate, carrier oils, or compounding ingredients in Bioniche Pharma preparations.

ADVERSE REACTIONS & SPECIAL PRECAUTIONS

• Dermatological & Androgenic: Heightened sebum production, severe acne vulgaris (frequently appearing across the face, shoulders, back, and arms during early treatment), and accelerated male pattern baldness (androgenetic alopecia).
• Behavioral & CNS: Dose-related increases in aggression, mood shifts, and irritability associated with Bioniche Pharma Trenbolone Enanthate therapy.
• Organ System Surveillance: Routine monitoring of cardiovascular health, liver enzyme levels, and kidney function is strongly recommended during treatment with Trenbolone Enanthate by Bioniche Pharma.
• Endocrine Suppression: Rapid and profound suppression of the Hypothalamic-Pituitary-Testicular Axis (HPTA), resulting in secondary hypogonadism and testicular atrophy.

DOSAGE & ADMINISTRATION

Trenbolone Enanthate by Bioniche Pharma is designed exclusively for deep intramuscular administration. The extended half-life of the enanthate ester allows for less frequent dosing intervals:

• Prescribed Dosage: Standard administration protocols typically involve 200 mg given 1 to 2 times weekly (totaling 200 mg to 400 mg weekly) via deep intramuscular injection, titrated according to medical guidance.
• Restricted Populations: Strictly contraindicated for use in female patients, children, and adolescents.

STORAGE & HANDLING

Store Bioniche Pharma Trenbolone Enanthate in a dry, cool environment shielded from direct sunlight and excessive heat. Do not refrigerate or freeze. Keep strictly out of the reach and sight of children.